Literature DB >> 26011811

Cancer incidence in Canada: trends and projections (1983-2032).

L Xie1, R Semenciw1, L Mery1.   

Abstract

PURPOSE AND INTENDED AUDIENCE: Each year, the Canadian Cancer Statistics publication provides an estimate of expected case counts and rates for common cancer sites for the current year in Canada as a whole and in the provinces and territories. This monograph expands on the Canadian Cancer Statistics publication by providing historical and projected cancer incidence frequencies and rates at national and regional levels from 1983 to 2032. The aim is that this monograph will be an important resource for health researchers and planners. Most importantly, it is hoped the monograph will: - provide evidence-based input for the development of public health policy priorities at the regional and national levels; and - guide public health officials in planning strategy including designing and evaluating preventive interventions and planning resources (treatment requirements) and infrastructure for future cancer control and care intended to reduce the burden of cancer in Canada.

Entities:  

Mesh:

Year:  2015        PMID: 26011811

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN: 2368-738X            Impact factor:   3.240


  16 in total

Review 1.  Non-immunotherapy options for the first-line management of hepatocellular carcinoma: exploring the evolving role of sorafenib and lenvatinib in advanced disease.

Authors:  S Perera; D Kelly; G M O'Kane
Journal:  Curr Oncol       Date:  2020-11-01       Impact factor: 3.677

2.  Locally advanced cervical cancer in a transgender man.

Authors:  Adam Beswick; Mark Corkum; David D'Souza
Journal:  CMAJ       Date:  2019-01-21       Impact factor: 8.262

3.  Childhood cancer incidence in Canada: demographic and geographic variation of temporal trends (1992-2010).

Authors:  Lin Xie; Jay Onysko; Howard Morrison
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-03       Impact factor: 3.240

Review 4.  Screening for breast cancer in 2018-what should we be doing today?

Authors:  J M Seely; T Alhassan
Journal:  Curr Oncol       Date:  2018-06-13       Impact factor: 3.677

5.  Translation and perceptions of the French version of the Cancer Survivor Profile-Breast Cancer (CSPro-BC): a tool to identify and manage unmet needs.

Authors:  Dominique Tremblay; Karine Bilodeau; Marie-José Durand; Marie-France Coutu
Journal:  J Cancer Surviv       Date:  2019-03-23       Impact factor: 4.442

6.  Update on cancer incidence trends in Canada, 1984 to 2017.

Authors:  Alain A Demers; Nathalie Saint-Jacques; Larry Ellison; Darren Brenner; Natalie Fitzgerald; Samina Aziz; Donna Turner
Journal:  Health Promot Chronic Dis Prev Can       Date:  2022-07       Impact factor: 2.725

7.  Epidemiology, clinical treatment patterns, and survival of hepatocellular carcinoma in Manitoba.

Authors:  Nikesh Hanumanthappa; Byung Heon Cho; Andrew McKay; David Peretz; Gerald Y Minuk; Pascal Lambert; Maged Nashed
Journal:  Can Liver J       Date:  2020-06-04

8. 

Authors:  Darren R Brenner; Abbey Poirier; Ryan R Woods; Larry F Ellison; Jean-Michel Billette; Alain A Demers; Shary Xinyu Zhang; Chunhe Yao; Christian Finley; Natalie Fitzgerald; Nathalie Saint-Jacques; Lorraine Shack; Donna Turner; Elizabeth Holmes
Journal:  CMAJ       Date:  2022-06-13       Impact factor: 16.859

9.  Prospective analysis of psychological differences between adult and elderly cancer patients during postoperative adjuvant chemotherapy.

Authors:  M M Muñoz-Sánchez; C Calderon; P Jimenez-Fonseca; M C Soriano-Rodríguez; C Jara; T García-García; C Beato; J Rogado; B Castelo; R Hernández; M Mangas-Izquierdo; A Carmona-Bayonas
Journal:  Clin Transl Oncol       Date:  2018-06-04       Impact factor: 3.405

10.  Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer.

Authors:  Meng-Hui Yuan; Long-Xiao Wei; Run-Suo Zhou; Hai-Feng Xu; Jun-Yan Wang; Qian-Rong Bai
Journal:  Oncol Lett       Date:  2017-10-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.